Mass Spectrometry-Based Direct Sequencing of tRNAs De Novo and Quantitative Mapping of Multiple RNA Modifications.
Xiaohong YuanYue SuBenjamin JohnsonMichele KirchnerXudong ZhangSihang XuSophia JiangJing WuShundi ShiJames J RussoQi ChenShenglong ZhangPublished in: Journal of the American Chemical Society (2024)
Despite the extensive use of next-generation sequencing (NGS) of RNA, simultaneous direct sequencing and quantitative mapping of multiple RNA nucleotide modifications remains challenging. Mass spectrometry (MS)-based sequencing can directly sequence all RNA modifications without being limited to specific ones, but it requires a perfect MS ladder that few tRNAs can provide. Here, we describe an MS ladder complementation sequencing approach (MLC-Seq) that circumvents the perfect ladder requirement, allowing de novo MS sequencing of full-length heterogeneous cellular tRNAs with multiple nucleotide modifications at single-nucleotide precision. Unlike NGS-based methods, which lose RNA modification information, MLC-Seq preserves RNA sequence diversity and modification information, revealing new detailed stoichiometric tRNA modification profiles and their changes upon treatment with the dealkylating enzyme AlkB. It can also be combined with reference sequences to provide quantitative analysis of diverse tRNAs and modifications in total tRNA samples. MLC-Seq enables systematic, quantitative, and site-specific mapping of RNA modifications, revealing the truly complete informational content of tRNA.
Keyphrases
- mass spectrometry
- high resolution
- single cell
- multiple sclerosis
- rna seq
- liquid chromatography
- ms ms
- nucleic acid
- genome wide
- gas chromatography
- healthcare
- capillary electrophoresis
- high performance liquid chromatography
- health information
- gene expression
- social media
- combination therapy
- smoking cessation
- simultaneous determination
- replacement therapy